Walgreens stock tumbles on report that private equity deal is unlikely
Shares of Walgreens Boots Alliance tumbled today following a CNBC report that the Deerfield-based pharmacy chain was unlikely to sell itself to a private-equity firm. CNBC’s David Faber reported on air this morning that sources say the possible deal in which Walgreens would sell itself to New York-based Sycamore Partners is “mostly dead.”
Walgreens Boots Alliance (NASDAQ:WBA) fell over 7% in extended trading on Thursday after the drugstore chain said it is ...
Check out who's buying and selling in this week's roundup of healthcare mergers, acquisitions and joint ventures.
Analyst Michael Cherny of Leerink Partners reiterated a Hold rating on Walgreens Boots Alliance (WBA – Research Report), retaining the price ...
"The company's cash needs over the next several years, including with respect to litigation and debt refinancing, were ...
The Wall Street Journal previously reported that Walgreens and Sycamore Partners were discussing a deal that could be ...
Sources told CNBC's David Faber that a private equity firm's prospective deal to acquire Walgreens Boots Alliance is ...
Pharmacy chain Walgreens has been struggling for over a year and has been in talks to sell to Sycamore Partners, a deal that is now "mostly dead." Meanwhile, some independent pharmacies are opting to ...
This is apparently happening to Walgreens Boots Alliance (NASDAQ: WBA), according to a media report. CNBC's David Faber ...
Rona, a portfolio company of Sycamore Partners, has acquired All-Fab Group (AFG), a provider of building products across Western Canada. Winnipeg-based AFG provides the light construction industry ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback